Formosa Pharmaceuticals has signed an exclusive licensing agreement with Cipla for the commercializa...
read moreBausch + Lomb has announced the U.S. launch of Arise, an advanced lens fitting system that leverages...
read moreOSRX is expanding its pharmaceutical offerings with new medication sizes and direct-to-patient post-...
read moreNicox has announced the completion of data collection for the Whistler Phase 3b clinical trial inves...
read moreHanAll Biopharma has received Orphan Drug Designation (ODD) from the Ministry of Health, Labor and W...
read moreIantrek Corporation has released promising results from its two-year clinical study on bio-reinforce...
read moreChina has approved SYCUME, the country’s first monoclonal antibody treatment for thyroid eye disease...
read moreStealth BioTherapeutics Inc. has achieved 50% of its enrollment target in the global Phase 3 ReNEW s...
read moreHarrow, a North American eyecare pharmaceuticals company, has introduced VEVYE Access For All, a new...
read more